E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/1/2009 in the Prospect News PIPE Daily.

New Issue: Bellus to sell C$20.5 million convertible notes

By Devika Patel

Knoxville, Tenn., April 1 - Bellus Health Inc. announced it will raise up to C$20.5 million in a private placement of five-year secured convertible notes.

Vitus Investments III Private Ltd. will buy C$10 million of notes and Victoria Square Ventures Inc. has committed to invest C$10.5 million.

The 15% notes are convertible at C$0.20 per share.

Based in Laval, Quebec, Bellus develops and markets health products.

Issuer:Bellus Health Inc.
Issue:Secured convertible notes
Amount:C$20.5 million
Maturity:Five years
Coupon:15%
Price:Par
Yield:15%
Conversion price:C$0.20
Warrants:No
Investors:Vitus Investments III Private Ltd. (for C$10 million) and Victoria Square Ventures Inc. (for C$10.5 million)
Pricing date:March 31
Stock symbol:Toronto: BLU
Stock price:C$0.28 at close April 1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.